Page 4 - Reference Panel News Today

Eurofins Awarded U.S. Government Agreement to Expand National COVID-19 Testing Regulatory News: Clinical Enterprise, Inc., a Eurofins Scientific (Paris:ERF) company, today announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing. The agreement with the U.S. Department of Health and Human Services, in coordination with the U.S. Department of Defense (DOD), will expand testing opportunities in K-8 schools, underserved populations and congregate settings such a...

Clinical Enterprise, Inc., a Eurofins Scientific company, today announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing. The agreement with the U.S. Department of

Share this article FRAMINGHAM, Mass., May 21, 2021 /PRNewswire/ -- Clinical Enterprise, Inc. d/b/a empowerDX, today announced its at-home COVID-19 testing kit received FDA-emergency use authorization for children three years and older. The direct-to-consumer company, owned by Eurofins Scientific, is the first to receive an EUA for an at-home PCR nasal test for young children. empowerDX launched its FDA-authorized at-home COVID test in the fall of 2020 to consumers 18 years and older. The com...

Strong Derry involvement in new panel set up to discuss issues around Irish unity New Ireland Commission established by the SDLP Denis Bradley is on the new panel announced by the SDLP. Reporter: );  ); There is a strong Derry involvement in a new panel set up the SDLP to discuss issues surrounding a united Ireland. The party has set up the New Ireland Commission to engage with every community, sector and generation on this island to build new proposals that can generate a consensus on our fu...

Share this article Share this article LEES SUMMIT, Mo., April 5, 2021 /PRNewswire/ -- Eurofins Viracor, a leader in infectious disease testing for over 35 years, announces the launch of cPass™ Coronavirus SARS-CoV-2 Neutralizing Antibody test. This test aids in the identification of recent or prior infection for SARS-CoV-2, the virus that causes COVID-19. The ELISA-based methodology detects neutralizing antibodies to the receptor binding domain (RBD) of the spike (S) protein. This test has b...

Tue, 09 Mar 2021 00:00 UTC US, UK, Canada, Australia, Switzerland and Singapore Will Let New-Variant Vaccines Onto the Market Without Safety or Efficacy Testing identical guidelines for fast-tracking release onto the market of vaccines for the new variants. The countries issued the recommendations under the banner of the ACCESS Consortium. ACCESS is an acronym based on the first letters of the five countries names. A few days earlier, on February 22, the US Food and Drug Administration (FDA) re...

Regulatory News: Eurofins (Paris:ERF): empowerDX, a Eurofins subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon.

Eurofins Scientific: Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon empowerDX, a Eurofins (Paris:ERF) subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID-19 tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus in both symptom...

Share this article (PRNewsfoto/empowerDX) FRAMINGHAM, Mass., March 10, 2021 /PRNewswire/ -- empowerDX, part of the Eurofins Clinical Diagnostics network, announced the launch of its direct-to-consumer, FDA-emergency use authorized, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus i...

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2 Friday, January 15, 2021 The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa. Eurofin...